期刊文献+

糖心合剂对2型糖尿病合并心功能不全患者心功能的影响 被引量:1

Effect of Tangxin Heji on Cardiac Function in Type Ⅱ Diabetic Patients with Heart Failure
原文传递
导出
摘要 目的探讨糖心合剂对2型糖尿病合并心功能不全患者心功能的影响。方法将49例2型糖尿病合并心功能不全患者随机分为对照组20例、治疗组29例,对照组采用西药常规治疗(强心剂、利尿剂、血管紧素转换酶抑制剂、β受体阻滞剂及硝酸酯类药物),治疗组在对照组基础上口服糖心合剂4粒,每日3次,共治疗12周。比较两组的临床疗效,心脏超声检测治疗前后左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、左室射血分数(EF)、左室短轴缩短率(FS)、E/A值,评价心功能。结果治疗组的临床总有效率为89.65%,对照组为60.00%,治疗组优于对照组(P<0.05);治疗组心功能各项指标均较治疗前明显改善,差异有统计学意义(P<0.05或P<0.01);对照组治疗后EF、FS较前有所好转(P<0.01),治疗组改善程度优于对照组(P<0.05或P<0.01)。结论糖心合剂能够改善2型糖尿病合并心功能不全患者的心功能。 Objective To investigate the effect of Tangxin Heji (Compound capsules for diabetic patients with cardiac insufficiency) on the cardiac function in type 2 diabetic patients with heart failure. Methods Totally 49 type Ⅱ diabetic patients were randomized into control group of 20 cases, and treatment group of 29 cases. The conventional therapy such as cardiotonic, diuretic, angiotension-converting enzyme inhibitor, J-receptor blocker, and nitrate medications were conducted in the control group. The treatment group was administered Tangxin Heji additionally on the basis of conventional therapy, 4 capsules each time, 3 times a day. The treatment lasted 12 weeks. The clinical effect of the two groups was compared. Before and after treatment, the left ventricular end diastolic diameter (LVEDD), the left ventricular end systolic diameter (LVESD), the left ventricle ejection fraction (EF), the left ventricle fraction shorting (FS), and the maximum systolic blood flow velocity of early diastolic / late diastolic (E/A) were detected by echocardiography for evaluating the heart function. Results The total effective rate of the treatment group and the control group were 89.65% and 60% respectively, the former was superior to the latter (P〈0.05). The heart function indices of the treatment group were improved and there was a statistical significance in difference (P〈0.05 or P〈0.01). The EF and FS of the control group were improved after treatment (P〈0.01), while the improvement in the treatment group was more than that of the control group (P〈0.05 or P〈0.01). The safety indices of both groups showed no obvious changes after treatment. Conclusion Tangxin Heji is effective and safe in improving the heart func- tion of Type Ⅱ diabetic patients with cardiac insufficiency.
出处 《中医杂志》 CSCD 北大核心 2011年第19期1658-1660,共3页 Journal of Traditional Chinese Medicine
基金 河北省科学技术研究与发展计划项目(08276101D-89)
关键词 糖心合剂 2型糖尿病 心功能不全 Tangxin Heji (Compound capsules for diabetic patients with cardiac insufficiency) type Ⅱ diabetes cardiac insufficiency
  • 相关文献

参考文献13

  • 1潘长玉,金文胜.2型糖尿病流行病学[J].中华内分泌代谢杂志,2005,21(5). 被引量:168
  • 2Gilbert RE, Krum H, Wilkinson-Berka J,et al. The re- nin angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic consider ations [J]. Diabet Med, 2003,20(8) :607 - 621. 被引量:1
  • 3Schannwell CM, Schneppenheim M, Perings S, et al. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy [J]. Cardiology, 2002,98 ( 1 - 2):33-39. 被引量:1
  • 4糖尿病诊疗标准(一)——美国糖尿病学会(ADA)2005年公布[J].国外医学(内分泌学分册),2005,25(6):436-437. 被引量:69
  • 5The Task Force for the Diagnosis and Treatment of A- cute and Chronic Heart Failure 2008 of the European So- ciety of Cardiology, Developed in collaboration with the Heart Failure Association of the ESC (HFA) and en- dorsed by the European Society of Intensive Care Medi- cine (ESICM). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008[J]. Eur Heart J,2008,29(19) :2388 - 2442. 被引量:1
  • 6赵水平编著..心血管病诊疗指南解读[M].北京:人民卫生出版社,2008:601.
  • 7中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58. 被引量:1253
  • 8Levy D. Long-term trends in the incidence of and surviv- al with heart failure [J]. New Engl J Med, 2002, 347 (18) :1397 - 1402. 被引量:1
  • 9刘红,刘凡,王海涛,李民强,安淑贤.慢性心力衰竭临床分级与超声心动图量化指标的比较分析[J].临床荟萃,2006,21(15):1089-1090. 被引量:7
  • 10Pignone M, Alberts MJ, Colweu JA, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes[J]. Ciurculation, 2010, 121 (24) : 2694 - 2701. 被引量:1

二级参考文献26

  • 1李美珠,钟伟新,李爱华,梁惠玲,雷坚,朱莉芬.舒心丸对实验性心力衰竭的治疗作用[J].中成药,1995,17(9):28-29. 被引量:6
  • 2张素华,余路,邱鸿鑫,李晨钟,古泉高,刘隆田,肖谦,粟绍初,李萍,吴应珍.家族性非胰岛素依赖型糖尿病患者的家系调查[J].中华医学杂志,1996,76(6):435-439. 被引量:53
  • 3Diabetic Cooperation Group of Fujian Province.福建省两次糖尿病调查对比报告[J].福建医科大学学报,1997,31(2):229-231. 被引量:3
  • 4李云霞.关于左室等容收缩相心收缩指标的实验研究.生理学报,1980,32(2):97-97. 被引量:7
  • 5Talbert,Robert L.Pharmacokinetics and Phannacodynamics of BetaBlockers in heart failure[J].Heart failure Reviews,2004,9:131. 被引量:1
  • 6Braunwald 陈灏珠(译).心脏病学(第5版)[M].北京:人民卫生出版社,1999.1100,1727-1729. 被引量:2
  • 7Ji XY, Tan BK, Zhu YZ. Salvia miltiorrhiza and ischemic diseases[J]. Acta Pharmacol Sin. 2000,21 ( 12 ): 1089-1094. 被引量:1
  • 8Sun J, Hong Huang S, Tan BK, et al. Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction[J]. Life Sci. 2005,76(24) :2849-2860. 被引量:1
  • 9Garcia EH,Perna E,Eduardo EF,et al.Reduced systolic perfomance by tissue Doppler in patients with preserved and abnormal ejection fraction:new insights in chronic heart failure[J].Int J Cardiol,2004,21(2):205-207. 被引量:1
  • 10Berg S,Torp H,Haugen BO,et al.Volumetric blood flow measurement with the use of dynamic 3-dimensional ultrasound color flow imaging[J].J Am Soc Echocardiog,2000,13(5):393-402. 被引量:1

共引文献1523

同被引文献19

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部